The Digital Health Market Unplugged Penetration Strategy
João Mendes-Roter, VP Patient Management Solutions at Itamar-Medical | Product-Marketing | Digital Health Expert | Business Growth Mentor.
Digital health is revolutionizing healthcare, offering personalized care pathways and enhancing the delivery of health services. Despite its promising potential, the sector faces significant challenges, including data security concerns, privacy issues, resistance to technological adoption, and the need for extensive training and infrastructure upgrades. Nonetheless, the opportunities presented by remote patient monitoring, data analytics and the expansion of digital health technologies to cover more disease states are substantial. To fully leverage these opportunities, the industry must develop a robust infrastructure to combat cybersecurity risks and navigate regulatory complexities.
State Of The Business
The Digital Health Market size has shown remarkable growth, reaching $240.85 billion in 2023. It is projected to reach $1.6 trillion by 2033, growing at an annual rate (CAGR) of 21.11% from 2024 to 2033. According to PitchBook, venture capital deals in digital health reached $1.1 billion in 77 total deals during the first quarter of 2024, marking a 6% quarter-over-quarter growth in the number of deals despite a decline in deal count growth.
However, the sustainability of certain digital health segments, particularly telehealth and digital therapeutics (DTx), remains a challenge due to low interest rates, unsustainable business models, and problematic mergers and acquisitions. Companies like Walmart’s MeMD and Optum’s virtual care service announced closures. Teladoc’s unsuccessful acquisition of Livongo and the impending delisting of Amwell from the New York Stock Exchange also demonstrated these struggles.
As of May, no publicly traded digital therapeutics companies remain. Virtual Therapeutics took Akili Interactive private for $34 million in May, and Better Therapeutics exited the market in March. Pear Therapeutics was sold for parts in 2023. PitchBook highlighted reimbursement issues as a major obstacle to profitability.
Despite these setbacks, opportunities remain in integrating DTx into general care platforms, condition management programs and building referral networks to establish trusted patient brands. Investment potential also lies in specialty telemedicine, B2B platforms and hybrid care models. Tech leaders should be on the watch for available partnerships and note that the platform flexibility and the business model design will be key to supporting these consolidations.
Key Investment Areas: Patient Engagement And Software Solutions
The shift toward personalized healthcare solutions and integrating digital tools in clinical practice is undeniable. DTx has emerged as a significant growth factor, offering evidence-based therapeutic interventions powered by software. These patient-facing applications help prevent, manage or treat medical disorders with clinically proven benefits, providing scalable and cost-effective alternatives to traditional therapies.
In 2023, the U.S. DTx market was valued at $1.95 billion and is projected to grow to $13.01 billion by 2033 at a CAGR of 20.9%. The software segment is expected to hold the largest market share during this period. The patient end-user segment dominated the overall market in 2023, accounting for more than 34.15% of revenue.
True, the diabetes management still commands the largest market share, driven by the high prevalence of diabetes nationwide. DTx applications enable real-time monitoring of blood glucose levels, physical activity and medication adherence, providing immediate feedback and personalized recommendations to patients. These tools enhance self-management and treatment adherence, improving outcomes and quality of life for diabetes patients.
But software solutions, which are projected to dominate throughout the forecast period, offer more than just diabetes management. They address disorders like obesity, ADHD, Type 2 diabetes, anxiety, depression and congestive heart failure, demonstrating their versatility and clinical impact in disease management. Tools include health-related tips, behavioral recommendations, medication reminders and exercise plans tailored to patient needs.
Tech leaders should keep a close eye on the employer sector in the U.S. They are increasingly focusing on controlling healthcare costs for employees. Offering DTx solutions has become a strategy to attract and retain talent, as employees prioritize employers who prioritize their health and well-being.
Sales Strategy: Product Innovation And Competitive Strategy
Developing tech solutions to enhance the efficiency of physicians and health professionals involves several critical steps. Each step ensures that the solutions are effective, user-friendly and seamlessly integrated into the healthcare environment.
First and foremost, tech leaders must foster collaboration among hospital IT staff, clinical users and technology providers through regular meetings. Involve physicians, nurses, administrators and other healthcare professionals in identifying pain points, and study workflows to understand where inefficiencies and bottlenecks exist. This is as important as the patient-consumerist approach to healthcare.
Second, involve clinical staff in the design phase to ensure solutions meet end-users’ needs, ensuring services integrate with existing electronic health record (EHR) systems, as well as promoting ongoing training opportunities, using agile methodologies for iterative improvements and adaptability.
Lastly, provide real-time monitoring, regularly gather user feedback, and update solutions based on changing needs. Designing solutions to handle increased usage and expanding to other departments as needed are crucial for interoperability and scale. This is how tech leaders will guarantee their advantage over the competition.
The Use Cases: Is It Worth It?
The industry shift toward preventative medicine and well-being, the rising prevalence of chronic disease states, the aim for personalized patient-centered care, the affordability of digital health care technology, the continuous monitoring capabilities, the opportunities to pair with medications, and empowering patients to be involved in their care is making the list of use cases rapidly grow, and along with it will be the market for these products.
To realize the full potential, several infrastructural elements must be addressed. Cybersecurity and privacy concerns are paramount, as data breaches could compromise patient information. The lack of federal infrastructure to regulate the influx of DTx products and the demand for connectivity to health systems must be addressed. Companies should consider patients without access to technology. Educational sessions will promote the use of products, and the incorporation of AI in healthcare settings will further enhance its impact.
Patient engagement, faster care pathways and proactive healthcare are facilitating chronic disease management and are the keys to reducing hospitalizations and the cost of disease progress of our aging population. Pharmacies can play a role in promoting DTx devices by engaging in conversations with patients/providers. Employers will push for the need, but will they put their money where their mouth is?
Forbes Communications Council is an invitation-only community for executives in successful public relations, media strategy, creative and advertising agencies. Do I qualify?
link